22 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. Oral and non-depot antipsychotics with less…
Medicine Compliance Aid Stability
LatudaCNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe)
CNX Therapeutics Ltd (formerly Sunovion Pharmaceuticals Europe)
Tablets f/c 18.5mg, 37mg, 74mg.
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light.
15 August 2022
Lactation Safety Information
No published evidence of safety
Low levels anticipated in milk due to the drug’s properties
Long half-life increases risk of accumulation in breastfed infants
9 November 2018